<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01742845</url>
  </required_header>
  <id_info>
    <org_study_id>P/2010/107</org_study_id>
    <nct_id>NCT01742845</nct_id>
  </id_info>
  <brief_title>Ultrasound-guided Intermediate Cervical Block Versus Superficial Cervical Block for Carotid Endarterectomy (CERVECHO)</brief_title>
  <acronym>CERVECHO</acronym>
  <official_title>Ultrasound-guided Intermediate Cervical Block Versus Superficial Cervical Block for Carotid : a Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective, randomised, controlled study is to compare the efficacy of
      ultrasound-guided intermediate cervical block to superficial block for carotid
      endarterectomy.

      Patients scheduled for carotide endarterectomy under regional anaesthesia (ropivacaine 4.75
      mg/ml) are randomised into 2 groups according to the technique of anaesthesia performed:
      superficial cervical block (Control group) or, ultrasound guided intermediate cervical block
      (Echo group). Main outcome is cervical block success, defined by surgery performed under
      regional anaesthesia without supplemental topical lidocaine. Secondary outcomes are rate of
      conversion to general anaesthesia, total dose of supplemental topical lidocaine and
      block-related complications.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cervical block success</measure>
    <time_frame>surgery time</time_frame>
    <description>carotid artery endarterectomy performed under regional anaesthesia without supplemental topical lidocaine.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>percentage of conversion to general anaesthesia</measure>
    <time_frame>surgery time</time_frame>
    <description>conversion to general anaesthesia for insufficient analgesia</description>
  </secondary_outcome>
  <other_outcome>
    <measure>percentage of patient needing intraoperative systemic analgesia or sedation</measure>
    <time_frame>anaesthesia time</time_frame>
    <description>if patient related pain in spite of supplemental local anaesthesic. sedation/analgesia let to the discretion of the anesthesist in the operating room</description>
  </other_outcome>
  <other_outcome>
    <measure>amount of local anaesthesic used to performed the block</measure>
    <time_frame>surgery time</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>regional anaesthesia-related complications</measure>
    <time_frame>7 postoperative days</time_frame>
    <description>Horner syndrom, facial paralysis, cough, phrenic paralysis</description>
  </other_outcome>
  <other_outcome>
    <measure>surgery related complications</measure>
    <time_frame>7 postoperative days</time_frame>
    <description>hematoma, stroke, bleeding</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Carotid Atherosclerosis</condition>
  <condition>Regional Anaesthesia Morbidity</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>landmark-based superficial cervical block is used. After insertion of the needle superficially below the skin, 20 to 30 ml of 4.75 mg/ml ropivacaine are injected fan-like in the subcutaneus plane.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>echo group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ultrasound-guided intermediate cervical block was performed. The probe is placed perpendicular to the skin, in the horizontal plane at the C3-C4 level. Needle is inserted in-plane. 10 ml ropivacaine 4.75mg/ml are injected under ultrasound control, 5 ml injected when needle is withdrawn under ultrasound control, 5 ml in the subcutaneous plane.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultrasound-guided administration of ropivacaine 4.75 mg/ml</intervention_name>
    <arm_group_label>echo group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>landmark based superfical ropivacaine 4.75 mg/ml injection</intervention_name>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient scheduled for elective carotid artery endarterectomy under regional
             anaesthesia

        Exclusion Criteria:

          -  indication for general anaesthesia

          -  known bleedind diathesis

          -  past medical allergy to local anaesthesic

          -  severe chronic pulmonary disease

          -  contralateral diaphragmatic motion abnormalities

          -  previous cervical ipsilateral surgery

          -  age &lt; 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pascal Petit, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU Besançon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sebastien Pili-Floury, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU Besançon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier universitaire de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 3, 2012</study_first_submitted>
  <study_first_submitted_qc>December 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2012</study_first_posted>
  <last_update_submitted>December 3, 2012</last_update_submitted>
  <last_update_submitted_qc>December 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ultrasound-guided</keyword>
  <keyword>regional anaesthesia</keyword>
  <keyword>Cervical block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Carotid Artery Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

